Skip to main content
SpringerLink
Log in

Die Beziehung zwischen der Guanethidin-Konzentration im Rattenherzen und dem Noradrenalingehalt

  • Published:
Naunyn-Schmiedebergs Archiv für experimentelle Pathologie und Pharmakologie Aims and scope Submit manuscript

Summary

Guanethidine was intravenously injected into rats and was subsequently determined in the hearts by extracting the tissue with trichloroacetic acid, purifying the extracts on cation exchange columns and by paper chromatography, and coupling the guanethidine with ninhydrin in alkaline solution before fluorimetric estimation. The concentration in the heart reached a maximum of 9 μg/g within 15 min of injecting 15 mg/kg, and was still 6.2 and 5.7 μg/g after 1 and 3 hours, respectively.

Guanethidine caused a decrease of the heart noradrenaline concentration, measured fluorimetrically, by 56% in 3 hours and by 93% in 14 hours. The adrenaline concentration was likewise decreased.

A metabolite with the guanidium group still intact was contained in the eluates of the ion exchange columns, but was separated from guanethidine by paper chromatography. The metabolite was detectable in heart extracts as soon as 6 min after injection of the drug, and the ratio of metabolite to guanethidine was then identical in heart and blood. The proportion in the heart rose steadily with time after injection, being about 50% after 3 hours. By this time 10–15% of the guanethidine administered had been excreted unchanged in the urine in addition to the metabolite mentioned.

The results indicate that guanethidine is rapidly concentrated and firmly held in the heart throughout the period of noradrenaline depletion.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

Literatur

  • Bertler, A., A. Carlsson andE. Rosengren: A method for the fluorimetric determination of adrenaline and noradrenaline in tissues. Acta physiol. scand.44, 273 (1958).

    Google Scholar 

  • Boura, A. L. A., F. C. Copp, W. G. Duncombe, A. F. Green andA. McCoubrey: The selective accumulation of bretylium in sympathetic ganglia and their post-ganglionic nerves. Brit. J. Pharmacol.15, 265 (1960).

    Google Scholar 

  • Brodie, B. B.: Storage and release of 5-hydroxytryptamine. 5-Hydroxytryptamine, p. 64. Ed. byG. P. Lewis. London: Pergamon Press 1958.

    Google Scholar 

  • Burn, J. H.: A new view of adrenergic nerve fibres, explaining the action of reserpine, bretylium, and guanethidine. Brit. med. J.1961 I, 1623.

    Google Scholar 

  • Cass, R., R. Kuntzman andB. B. Brodie: Norepinephrine depletion as a possible mechanism of action of guanethidine, a new hypotensive agent. Proc. Soc. exp. Biol. (N. Y.)103, 871 (1960).

    Google Scholar 

  • ——, andT. L. Spriggs: Tissue amine levels and sympathetic blockade after guanethidine and bretylium. Brit. J. Pharmacol.17, 442 (1961).

    Google Scholar 

  • Conn, R. B.: Fluorimetric determination of creatine. Clin. Chem.6, 537 (1960).

    Google Scholar 

  • ——, andR. B. Davis: Green fluorescence of guanidium compounds with ninhydrin. Nature (Lond.)183, 1053 (1959).

    Google Scholar 

  • Crout, J. R., C. R. Creveling andS. Udenfriend: Norepinephrine metabolism in rat brain and heart. J. Pharmacol. exp. Ther.132, 269 (1961).

    Google Scholar 

  • Dollery, C. T., D. Emslie-Smith andM. D. Milne: Clinical and pharmacological studies with guanethidine in the treatment of hypertension. Lancet1960 II, 381.

    Google Scholar 

  • Hess, S. M., P. A. Shore andB. B. Brodie: Persistence of reserpine action after the disappearance of drug from brain: Effect on serotonin. J. Pharmacol. exp. Ther.118, 84 (1956).

    Google Scholar 

  • Huković, S., u.E. Muscholl: Die Noradrenalin-Abgabe aus dem isolierten Kaninchenherzen bei sympathischer Nervenreizung und ihre pharmakologische Beeinflussung. Naunyn-Schmiedeberg's Arch. exp. Path. Pharmak.244, 81 (1962).

    Google Scholar 

  • McCubbin, J. W., Y. Kaneko andI. H. Page: The peripheral cardiovascular actions of guanethidine in dogs. J. Pharmacol. exp. Ther.131, 346 (1961).

    Google Scholar 

  • Sanan, S., andM. Vogt: Effect of drugs on the noradrenaline content of brain and peripheral tissues and its significance. Brit. J. Pharmacol.18, 109 (1962).

    Google Scholar 

  • Tompsett, S. L.: The separation of alkaloids and related substances from urinethe use of cation exchange resins. Acta pharmacol. (Kbh.)17, 295 (1960).

    Google Scholar 

  • ——W. Forshall andD. C. Smith: The identification and determination of some hypotensive drugs in urine. Acta pharmacol. (Kbh.)18, 75 (1961).

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Aus dem Pharmakologischen Institut der Universität Mainz, Germany

    Gabriele M. Bisson & E. Muscholl

Authors
  1. Gabriele M. Bisson
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. E. Muscholl
    View author publications

    You can also search for this author in PubMed Google Scholar

Additional information

Mit 2 Textabbildungen

Rights and permissions

Reprints and permissions

About this article

Cite this article

Bisson, G.M., Muscholl, E. Die Beziehung zwischen der Guanethidin-Konzentration im Rattenherzen und dem Noradrenalingehalt. Naunyn - Schmiedebergs Arch 244, 185–194 (1962). https://doi.org/10.1007/BF00738224

Download citation

  • Received:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00738224

Search

Navigation